Cardiovascular Systems, Inc.
2715 Nevada Avenue North
New Hope
Minnesota
55427
United States
Tel: 763-544-1890
296 articles about Cardiovascular Systems, Inc.
-
Cardiovascular Systems, Inc. to Participate at the 20th Annual Needham Healthcare Conference
3/24/2021
Cardiovascular Systems, Inc. to Participate at the 20 th Annual Needham Healthcare Conference
-
Cardiovascular Systems, Inc. Announces Acquisition of Peripheral Support Catheters From WavePoint Medical, LLC
3/22/2021
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII) announced today that it has acquired a line of peripheral support catheters from WavePoint Medical, LLC.
-
Cardiovascular Systems, Inc. Announces First Uses of WIRION® Embolic Protection System
3/17/2021
Cardiovascular Systems, Inc. Announces First Uses of WIRION ® Embolic Protection System Device offers a streamlined approach for lower extremity embolic protection
-
Cardiovascular Systems, Inc. to Participate at Four Upcoming Investor Conferences
2/11/2021
Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that management plans to present and host investor meetings at three upcoming conferences. Webcasts of each of the presentations will be made available on CSI's website.
-
First Patient in Europe Treated With Cardiovascular Systems, Inc. Diamondback 360® Coronary Orbital Atherectomy System
2/8/2021
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that the first patient in Europe has been treated with its Diamondback 360® Coronary Orbital Atherectomy System (OAS).
-
Cardiovascular Systems, Inc. Reports Fiscal 2021 Second-quarter Financial Results
2/3/2021
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today reported financial results for its fiscal second quarter, ended December 31, 2020.
-
Cardiovascular Systems, Inc. Announces Partnership With Chansu Vascular Techologies, LLC to Develop New Drug-Coated Balloon Technology
2/1/2021
Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII) announced today that it has partnered with Chansu Vascular Technologies, LLC (CVT) to develop novel peripheral and coronary everolimus drug-coated balloons (DCBs).
-
Cardiovascular Systems, Inc. Announces Sachin H. Jain, MD, MBA, Joins Board of Directors
1/27/2021
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced the addition of independent board member Sachin H. Jain, MD, MBA.
-
Cardiovascular Systems, Inc. Receives CE Mark for Diamondback 360® Coronary Orbital Atherectomy System
1/18/2021
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that it has received CE Mark for its Diamondback 360® Coronary Orbital Atherectomy System (OAS) and ViperWire Advance® Coronary Guide Wire with Flex Tip
-
Cardiovascular Systems, Inc. to Webcast Fiscal 2021 Second-Quarter Earnings Conference Call Wednesday, February 3
1/13/2021
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII) will host a live webcast of its fiscal 2021 second-quarter conference call on Wednesday, February 3, 2021, at 3:30 p.m. CT (4:30 p.m. ET).
-
Cardiovascular Systems, Inc. to Present at the Stifel 2020 Virtual Healthcare Conference
11/11/2020
On Wednesday, November 18, 2020, Cardiovascular Systems’ (NASDAQ: CSII) Chairman, President and Chief Executive Officer, Scott Ward, will present at the Stifel 2020 Virtual Healthcare Conference at 3:20 p.m. Eastern Time. You may access the live audio webcast, as well as a replay on the company’s investor relations website, https://investors.csi360.com/events-and-presentations/events-calendar/default.aspx . A
-
Cardiovascular Systems, Inc. Reports Fiscal 2021 First-Quarter Financial Results
11/4/2020
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today reported financial results for its fiscal first quarter, ended September 30, 2020.
-
Cardiovascular Systems, Inc. to Webcast Fiscal 2021 First-Quarter Earnings Conference Call Wednesday, November 4
10/21/2020
Cardiovascular Systems, Inc. will host a live webcast of its fiscal 2021 first-quarter conference call on Wednesday, November 4, 2020, at 3:30 p.m. CT.
-
Large Study Demonstrates Exceptional Safety and High Procedural Success With Cardiovascular Systems’ Diamondback 360® Coronary Orbital Atherectomy System (OAS)
10/14/2020
Large Study Demonstrates Exceptional Safety and High Procedural Success With Cardiovascular Systems’ Diamondback 360 ® Coronary Orbital Atherectomy System (OAS) ST. PAUL, Minn.--( BUSINESS WIRE )-- Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that results from a large retrosp
-
Cardiovascular Systems Announces Presentation of Data From Large Coronary Orbital Atherectomy Study at the TCT Connect 2020 Conference
10/7/2020
Cardiovascular Systems, Inc., a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced that results from a large retrospective observational study of coronary orbital atherectomy will be released at TCT Connect 2020.
-
Cardiovascular Systems, Inc. Announces Kelvin Womack Joins Board of Directors
8/20/2020
Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced the addition of independent board member Kelvin Womack. Womack is currently the Vice President for Diversity and Inclusion at St. Jude Children’s Research Hospital in Memphis, Tenn. Prior t
-
Cardiovascular Systems, Inc. Reports Fiscal 2020 Fourth-Quarter Financial Results
8/4/2020
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today reported financial results for its fiscal fourth quarter, ended June 30, 2020.
-
Cardiovascular Systems Presents REACH PVI Study at the New Cardiovascular Horizons Conference
7/27/2020
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that the results from its REACH PVI study were presented at the New Cardiovascular Horizons (NCVH) Conference.
-
Cardiovascular Systems, Inc. to Webcast Fiscal 2020 Fourth-Quarter Earnings Conference Call Tuesday, August 4
7/14/2020
Cardiovascular Systems, Inc. will host a live webcast of its fiscal 2020 fourth-quarter conference call on Tuesday, August 4, 2020, at 3:30 p.m. CT.
-
Cardiovascular Systems Announces Exercise of Underwriters’ Option
6/18/2020
Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that the underwriters of its recent public offering of common stock have fully exercised their option resulting in the issuance of an additional 551,470 shares.